河南医学研究
河南醫學研究
하남의학연구
HENAN MEDICAL RESEARCH
2014年
12期
10-13
,共4页
别亚男%乔俊静%王瑾%张昭%秦艳茹
彆亞男%喬俊靜%王瑾%張昭%秦豔茹
별아남%교준정%왕근%장소%진염여
Crnn基因%食管鳞癌%组织芯片
Crnn基因%食管鱗癌%組織芯片
Crnn기인%식관린암%조직심편
Crnn gene%esophageal squamous cell carcinoma%tissue chip
目的::研究Crnn蛋白在食管鳞癌组织( ESCC)中的表达及其在ESCC发生、发展及预后中的作用。方法:采用免疫组织化学方法检测组织阵列仪取样的100例ESCC组织(观察组)和相应正常食管组织(对照组)中Crnn蛋白的表达情况,并探讨其与ESCC患者年龄、性别、肿瘤细胞分化程度、淋巴结转移、TNM分期、大体分型和5年生存率的关系。结果:ESCC组织中Crnn蛋白表达阳性率(45.6%)明显低于正常组织中的表达阳性率(93.7%)(P<0.05);肿瘤组织Crnn表达下调率为53.2%;Crnn基因表达与淋巴结转移、TNM分期有关,而与年龄、性别、肿瘤细胞分化程度、和大体分型无关;Crnn蛋白表达下调的食管鳞癌患者的5年生存率明显低于Crnn蛋白正常表达的食管鳞癌患者。结论: Crnn基因表达下调可能会促进食管鳞癌的发生、发展,是食管鳞癌组织中候选的抑癌基因。
目的::研究Crnn蛋白在食管鱗癌組織( ESCC)中的錶達及其在ESCC髮生、髮展及預後中的作用。方法:採用免疫組織化學方法檢測組織陣列儀取樣的100例ESCC組織(觀察組)和相應正常食管組織(對照組)中Crnn蛋白的錶達情況,併探討其與ESCC患者年齡、性彆、腫瘤細胞分化程度、淋巴結轉移、TNM分期、大體分型和5年生存率的關繫。結果:ESCC組織中Crnn蛋白錶達暘性率(45.6%)明顯低于正常組織中的錶達暘性率(93.7%)(P<0.05);腫瘤組織Crnn錶達下調率為53.2%;Crnn基因錶達與淋巴結轉移、TNM分期有關,而與年齡、性彆、腫瘤細胞分化程度、和大體分型無關;Crnn蛋白錶達下調的食管鱗癌患者的5年生存率明顯低于Crnn蛋白正常錶達的食管鱗癌患者。結論: Crnn基因錶達下調可能會促進食管鱗癌的髮生、髮展,是食管鱗癌組織中候選的抑癌基因。
목적::연구Crnn단백재식관린암조직( ESCC)중적표체급기재ESCC발생、발전급예후중적작용。방법:채용면역조직화학방법검측조직진렬의취양적100례ESCC조직(관찰조)화상응정상식관조직(대조조)중Crnn단백적표체정황,병탐토기여ESCC환자년령、성별、종류세포분화정도、림파결전이、TNM분기、대체분형화5년생존솔적관계。결과:ESCC조직중Crnn단백표체양성솔(45.6%)명현저우정상조직중적표체양성솔(93.7%)(P<0.05);종류조직Crnn표체하조솔위53.2%;Crnn기인표체여림파결전이、TNM분기유관,이여년령、성별、종류세포분화정도、화대체분형무관;Crnn단백표체하조적식관린암환자적5년생존솔명현저우Crnn단백정상표체적식관린암환자。결론: Crnn기인표체하조가능회촉진식관린암적발생、발전,시식관린암조직중후선적억암기인。
Objective: To investigate the expression of Crnn in human esophageal squamous cell carcinoma( ESCC) and the role of Crnn in the occurrence, development and prognosis of ESCC. Methods:The expression levels of Crnn in 100 ESCC tissues ( observation group ) were compared with that in corresponding normal esophageal tissues( control group) by immunohistochemical tech-niques. Its correlation with age, gender, tumor-cell differentiation, lymph-node metastasis, TNM stage, general classification and five-year survival rate of ESCC patients were analyzed. Results:The expression rate of Crnn in the observation group was 45 . 6%, which was obviously lower than the control group (93. 7%), the down-regulation rate of Crnn in tumor tissues was 53. 2%, the expression of Crnn gene was correlated with lymph nodes metastasis and TMN stage, but not with age, gender, tumor-cell differentiation and general classification. The five-year survival rate of ES-CC patients with the down expression of Crnn gene was lower than ESCC patients with normal ex-pression of Crnn gene. Conclusion: The down expression of Crnn gene may promote the occur-rence and development of ESCC. Crnn was the candidate tumor suppressor gene of ESCC.